kabutan

PhoenixBio Co.,Ltd., The Current Fiscal Year Ordinary Profit Revised Downward to a Loss

Thu Nov 14, 2024 3:30 pm JST Earnings

6190 PhoenixBio Co.,Ltd. 【J-GAAP】

Earnings Report

PhoenixBio Co.,Ltd. <6190> [TSE-G] announced its financial results after the market closed on November 14th (15:30). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending March 2025 (April to September) turned into a loss of 123 million yen (compared to a profit of 45 million yen in the same period last year), further increasing the deficit beyond the forecast of a loss of 5 million yen.

In addition, the full-year consolidated ordinary profit/loss has been revised downward from an expected profit of 214 million yen to a loss of 277 million yen (compared to a profit of 43 million yen in the previous period), turning to a loss outlook.

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary loss for the October to March period (second half) is expected to expand to a loss of 154 million yen (compared to a loss of 2 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the consolidated ordinary loss expanded to a loss of 148 million yen (compared to a loss of 2 million yen in the same period last year). The operating profit/loss margin drastically worsened from -2.7% in the same period last year to -30.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 1,135 367 403 356 107.7 78.9 Nov 14, 2022 J-GAAP
Apr - Sep, 2023 881 -5 45 27 7.5 104.7 Nov 14, 2023 J-GAAP
Apr - Sep, 2024 788 -98 -123 -124 -30.9 ー Nov 14, 2024 J-GAAP
YoY -10.6% -1,860.0% － － －

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance 972 -5 -5 -8 -2.0 0 May 15, 2024 J-GAAP
Apr - Sep, 2024 Results 788 -98 -123 -124 -30.9 0 Nov 14, 2024 J-GAAP
Revision Rate -18.9% -1,860.0% -2,360.0% -1,450.0% -1,468.0%

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 2,121 214 214 201 49.6 0 May 15, 2024 J-GAAP
Mar, 2025 New 1,521 -253 -277 -281 -69.4 0 Nov 14, 2024 J-GAAP
Revision Rate -28.3% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 834 16 -2 -1 -0.3 0 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 733 -155 -154 -157 -38.8 0 Nov 14, 2024 J-GAAP
YoY -12.1% － -7,600.0% -15,600.0% -14,255.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,124 508 511 493 145.2 0 May 15, 2023 J-GAAP
Mar, 2024 1,715 11 43 26 7.0 0 May 15, 2024 J-GAAP
Mar, 2025 Guidance 1,521 -253 -277 -281 -69.4 0 Nov 14, 2024 J-GAAP
YoY -11.3% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 442 -12 -2 -15 -4.2 -2.7 Nov 14, 2023 J-GAAP
Oct - Dec, 2023 447 35 -13 -13 -3.6 7.8 Feb 14, 2024 J-GAAP
Jan - Mar, 2024 387 -19 11 12 3.2 -4.9 May 15, 2024 J-GAAP
Apr - Jun, 2024 449 5 25 23 5.8 1.1 Aug 13, 2024 J-GAAP
Jul - Sep, 2024 339 -103 -148 -147 -36.6 -30.4 Nov 14, 2024 J-GAAP
YoY -23.3% -758.3% -7,300.0% -880.0% -776.1%

Related Articles